Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 21, 2017; 23(39): 7139-7149
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7139
Table 1 Enteropathic spondyloarthritis patient features
ES-AN, n = 52ES-AN/Ada, n = 30
Crohn’s disease:Ulcerative colitis31 (60):21 (40)19 (63):11 (37)
Males:Females22 (42):30 (58)17 (57):13 (43)
Age in years47.2 ± 14.246.2 ± 14.4
Disease duration of IBD in years11.3 ± 10.18.8 ± 7.9
Smokers:Ex-smokers9 (17):20 (38)
HLA-B27 positivity5 (10)4 (13)
Prior surgical intervention for IBD13 (25)5 (17)
Previous extra-intestinal disease6 (11)5 (17)
Eritema nodosum21
Uveitis33
Pioderma gangrenosum11
Crohn’s disease activity by CDAI
Inactive14 (45)7 (37)
Moderate10 (32)8 (42)
Moderate-to-Severe7 (23)4 (21)
Ulcerative colitis activity by partial Mayo
Mild18 (86)8 (73)
Moderate3 (14)3 (27)
Severe00
Current medication at baseline
Non-steroids anti-inflammatory drugs30
Sulfasalazine32
Mesalazine2512
Cyclosporine11
Azathioprine95
Oral steroids127
Topical steroids32
Metotrexate21
Infliximab64
Adalimumab20
Spondyloarthritis features
Ankylosing spondylitis according to Modified New York Criteria16 (31)10 (33)
Non-radiographic Axial-Spondyloarthritis by ASAS Criteria13 (25)10 (33)
Peripheral- Spondyloarthritis23 (44)10 (33)
Type of axial involvementn = 29n = 20
Syndesmophytosis8 (28)6 (30)
Bamboo spine2 (7)2 (10)
Sacroiliitis by MRI and/or X-ray29 (100)20 (100)
Type of articular involvement in Crohn’s diseasen = 31n = 19
Axial16 (52)11 (58)
Axial and peripheral43
Peripheral only15 (48)8 (42)
Enthesitis9 (29)5 (26)
Type of articular involvement in ulcerative colitisn = 21n = 11
Axial13 (62)9 (82)
Axial and peripheral95
Peripheral only8 (38)2 (18)
Enthesitis4 (19)2 (18)